Thanks Grassin123 for this much needed clarifier, it's a pity the company did not provide the details. My preliminary research indicates it's going to be very hard to get the CE on the information I been trying to get on whatever clinical trials have already been done seem rather minimal or maybe they are held secretly so outsiders will never know about them maybe.
Accordingly I have put osl.in the too hard basket and treating it as highly speculative play totally dependent on a slim possibility the CE authority will go soft on their requirements or I got it totally wrong and they get they'll clear to proceed. Imo if it get a green light to proceed it will have lots conditions which might delay bringing to market for several more years and require several CR over future years to enable more studies. If I'm wrong then current holders might make a mozza. Imo at current sp its too high for the risk of a possible totally disappointing result, but GLTA the courageous holders of OSL.
- Forums
- ASX - By Stock
- News: OncoSil Medical completes Fast Track Face-to-Face for CE Mark
OSL
oncosil medical ltd
Add to My Watchlist
5.69%
!
$1.16

Thanks Grassin123 for this much needed clarifier, it's a pity...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 412 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
1 | 2500 | 1.030 |
1 | 550 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 412 | 1 |
1.200 | 8677 | 1 |
1.245 | 2418 | 1 |
1.250 | 46027 | 1 |
1.300 | 1500 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online